Simultaneous determination of HIV protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir in human plasma by high-performance liquid chromatography-tandem mass spectrometry

This publication has 43 references indexed in Scilit:

• Simultaneous Quantitative Assay of Atazanavir and 6 Other HIV Protease Inhibitors by Isocratic Reversed-Phase Liquid Chromatography in Human Plasma
  Therapeutic Drug Monitoring, 2005
• Simultaneous determination of the antiretroviral agents: amprenavir, lopinavir, ritonavir, saquinavir and efavirenz in human peripheral blood mononuclear cells by high-performance liquid chromatography–mass spectrometry
  Journal of Chromatography B, 2004
• Drug Interactions Between Antiretroviral Drugs and Comedicated Agents
  Clinical Pharmacokinetics, 2003
• PharmAdapt
  AIDS, 2002
• Interactions among Drugs for HIV and Opportunistic Infections
  New England Journal of Medicine, 2001
• Lipid Abnormalities During Saquinavir Soft-Gel–Based Highly Active Antiretroviral Therapy
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
• Pharmacokinetics and Potential Interactions Amongst Antiretroviral Agents Used To Treat Patients with HIV Infection
  Clinical Pharmacokinetics, 1999
• Human immunodeficiency virus type 1 protease inhibitors
  Archives of internal medicine (1960), 1997
• Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments
  JAMA, 1986
• INACTIVATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS BY HEAT, GAMMA RAYS, AND ULTRAVIOLET LIGHT
  The Lancet, 1985